Mastodon

Oxycort (Aerosol) Instructions for Use

Marketing Authorization Holder

Tarchomin Pharmaceutical Works Polfa, S.A. (Poland)

Contact Information

Tarchomin Pharmaceutical Works Polfa, S.A. (Poland)

ATC Code

D07CA01 (Hydrocortisone in combination with antibiotics)

Active Substances

Hydrocortisone

Oxytetracycline

Dosage Form

Bottle Rx Icon Oxycort Aerosol for external use 300 mg+100 mg/55 ml: aerosol bottles

Dosage Form, Packaging, and Composition

Aerosol for external use in the form of a homogeneous yellow suspension, free from mechanical inclusions, with a characteristic odor.

1 bottle
Oxytetracycline hydrochloride 300 mg
Hydrocortisone 100 mg

Excipients: sorbitan trioleate (Span 85V) – 640 mg, lecithin – 4.87 mg, isopropyl myristate – up to 5.25 g, a mixture of propane, butane, and isobutane (Drivosol 35A) as a propellant – 27 g.

55 ml – aerosol bottles (1) with a valve and spray device – cardboard packs.

Clinical-Pharmacological Group

A drug with antibacterial and anti-inflammatory action for external use

Pharmacotherapeutic Group

Topical glucocorticosteroid + tetracycline antibiotic

Pharmacological Action

Oxycort is a drug for external use that has the combined action of two active components.

Oxytetracycline is a broad-spectrum antibiotic from the tetracycline group. It has a bacteriostatic effect on some Gram-positive bacteria: streptococci; Gram-negative bacteria: Enterobacteriaceae, Pseudomonadaceae, Pasteurellaceae (Haemophilus spp.), cocci (Neisseria spp.). It is active against microorganisms of the families Rickettsiaceae, Chlamydiaceae, Mycoplasma, Actinomyces, as well as some protozoa (Plasmodium, Entamoeba).

Hydrocortisone is a synthetic glucocorticosteroid of the adrenal cortex. It has anti-inflammatory, anti-allergic, antipruritic, and anti-edematous effects.

Pharmacokinetics

Oxytetracycline, when applied externally, is practically not absorbed into the blood and does not have a systemic effect. Hydrocortisone may slightly penetrate into the systemic circulation, is metabolized in the liver, and is excreted by the kidneys.

Violation of the integrity of the skin, inflammatory and other pathological processes of the skin, and an occlusive dressing promote the absorption of the drug.

Indications

  • Allergic skin diseases complicated by secondary bacterial infection (urticaria, eczema);
  • Skin diseases caused by microorganisms sensitive to oxytetracycline, as well as mixed infections (impetigo, furunculosis, folliculitis, multiple abscesses, erysipelas);
  • First-degree burns and frostbite;
  • Secondary infections after insect bites.

ICD codes

ICD-10 code Indication
A46 Erysipelas
L01 Impetigo
L02 Cutaneous abscess, furuncle and carbuncle
L03 Cellulitis
L08.0 Pyoderma
L08.9 Local infection of skin and subcutaneous tissue, unspecified
L50.0 Allergic urticaria
L73.9 Disease of hair follicles, unspecified
T30 Burns and corrosions of unspecified body region
T33 Superficial frostbite
T79.3 Posttraumatic wound infection, not elsewhere classified
ICD-11 code Indication
1B70.0Z Erysipelas, unspecified
1B70.1 Streptococcal cellulitis of the skin
1B70.2 Staphylococcal cellulitis of the skin
1B70.Z Bacterial cellulitis or lymphangitis caused by unspecified bacterium
1B72.0 Bullous impetigo
1B72.1 Nonbullous impetigo
1B72.Z Impetigo, unspecified
1B75.0 Furuncle
1B75.1 Carbuncle
1B75.2 Furunculosis
1B75.3 Pyogenic skin abscess
1B7Y Other specified pyogenic bacterial infections of skin or subcutaneous tissue
EB00.0 Acute urticaria
EB21 Pyoderma gangrenosum
EG30.0 Folliculitis of the scalp
EK10.Z Allergic contact urticaria, unspecified
EK5Y Other specified skin lesions provoked by exposure to external factors
EM0Z Unspecified skin disorder
NE11 Burn of unspecified body region
NE40 Superficial frostbite
NF0A.3 Posttraumatic wound infection, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Use externally only. Shake the aerosol bottle vigorously immediately before each application.

Hold the bottle in a vertical position. Spray the affected skin areas from a distance of 15-20 cm for 1-3 seconds.

Apply the spray 2 to 4 times daily. Maintain equal time intervals between applications.

Limit the treatment course duration to avoid potential adverse effects. Do not use on large body surface areas.

Avoid contact with eyes, mouth, and other mucous membranes. In case of accidental contact, rinse thoroughly with cool water.

Do not inhale the aerosol spray. Do not apply to open or deep wounds without medical supervision.

Discontinue use and consult a physician if no improvement is observed within 3-5 days, or if irritation worsens.

Do not puncture or incinerate the aerosol container, even after use. Store away from heat and open flames.

Adverse Reactions

Local reactions: burning, itching, irritation at the site of drug application, dryness and atrophy of the skin, acne-like rash, secondary infections. Long-term use of the drug on the facial skin may lead to dilation of blood vessels, as well as skin atrophy.

Development of systemic action is possible: suppression of the hypothalamic-pituitary-adrenal system. These effects may occur with long-term use of the drug and application to a large skin surface.

Contraindications

  • Hypersensitivity to the components of the drug;
  • Skin tuberculosis;
  • Viral and fungal skin infections;
  • Skin tumors and neoplasms.

Use in Pregnancy and Lactation

The use of the drug during pregnancy and lactation is contraindicated.

Special Precautions

In case of skin irritation, the drug should be discontinued and appropriate measures initiated.

The use of oxytetracycline and other broad-spectrum antibiotics may lead to an increase in the number of resistant strains of staphylococci and Candida albicans. If an infection caused by resistant strains of bacteria or yeast fungi develops, appropriate treatment should be initiated.

The drug should not be applied to a large skin surface due to the possibility of adverse reactions characteristic of systemic steroid drugs, including suppression of the hypothalamic-pituitary-adrenal system (including symptoms of Cushing’s syndrome, glucosuria). In these cases, it is necessary to interrupt treatment and monitor the level of cortisol in the urine.

Long-term use of the drug on the skin may lead to dilation of blood vessels and skin atrophy.

It is necessary to protect the eyes from the aerosol. Do not inhale the sprayed drug. In case of contact with mucous membranes, rinse them thoroughly with cool water.

The bottle must not be opened or heated, as the contents of the bottle are under pressure and are highly flammable.

Effect on the ability to drive vehicles and mechanisms

The drug does not cause psychophysical impairments and does not affect the ability to drive vehicles.

Overdose

No symptoms of overdose have been observed with topical application of the drug.

Drug Interactions

Not established with topical application of the drug.

Storage Conditions

The drug should be stored out of the reach of children at a temperature not exceeding 25°C.

Shelf Life

Shelf life – 2 years. Do not use after the expiration date printed on the packaging.

Dispensing Status

The drug is dispensed by prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS